Cargando…
Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature
Background: Anti-IgLON5 disease is a novel disorder with a complex interplay between inflammation and neurodegeneration. Patients develop antibodies against IgLON5 but also deposition of neuronal tau protein. Symptoms often have an insidious onset, slow progression and mimic other neurological disor...
Autores principales: | Nissen, Mette Scheller, Blaabjerg, Morten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783555/ https://www.ncbi.nlm.nih.gov/pubmed/31632341 http://dx.doi.org/10.3389/fneur.2019.01056 |
Ejemplares similares
-
Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human Neurons
por: Ryding, Matias, et al.
Publicado: (2021) -
Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Case Report: Neuropsychological Findings in IgLON5 Antibody Disorder
por: El Shazly, Jasmin, et al.
Publicado: (2021) -
Understanding anti-IgLON5 disease
por: Graus, Francesc, et al.
Publicado: (2017)